|
Age in years, median (P25–75)
|
70 (60–75)
|
|
Age group, n (%)
| |
|
≥ 65 years
|
43 (68)
|
|
< 65 years
|
20 (32)
|
|
Sex, n (%)
| |
|
Male
|
48 (76)
|
|
Female
|
15 (24)
|
|
Body Mass Index in Kg/m2, median (P25–P75)
|
25 (24–28)
|
|
General anesthesia/Regional anesthesia, n. (%)
|
24 (38)/39 (62)
|
|
Duration of anesthesia (min.) median (P25–P75)
|
160 (140–180)
|
|
Temperature at admission on PACU, mean ± sd
|
35.8 ± 0.81
|
|
Troponin I at admission, mean ± sd
|
0.027 ± 0.22
|
|
Hypertension, n (%)
|
60 (95)
|
|
Hyperlipidemia, n (%)
|
53 (84)
|
|
Ischemic heart disease, n (%)
|
41 (65)
|
|
Congestive heart disease, n (%)
|
5 (8)
|
|
Cerebrovascular disease, n (%)
|
34 (54)
|
|
Insulin therapy for diabetes, n (%)
|
3 (5)
|
|
Preoperative serum creatinine > 2 mg/dl
|
1 (2)
|
|
Total RCRI, mean ± sd
|
1.35 ± 0.85
|
|
High-risk patients, n (%)
|
14 (22.2)
|
|
Neurological evaluation
| |
|
Asymptomatic
|
13 (21)
|
|
Severe bilateral carotid disease
|
19 (30)
|
|
Amaurosis
|
4 (6)
|
|
Transient ischaemic attack
|
15 (24)
|
|
Stroke with full recovery
|
6 (10)
|
|
Stroke with residual deficit
|
13 (21)
|
|
Katz scale, mean ± sd
|
0.22 ± 0.72
|
|
Dependency in I-ADL, n (%)
|
7 (11)
|
|
Lawton I-ADL scale, mean ± sd
|
6.1 ± 1.9
|
|
Dependency in P-ADL, n (%)
|
14 (22)
|
|
SAPS II, median (P25–75)
|
16 (12–21)
|
|
APACHE II, median (P25–75)
|
7 (6–10)
|
|
PACU length of stay (hours), median (P25–75)
|
21 (16–22)
|
|
Hospital length of stay (days), median (P25–75)
|
5 (4–7)
|
|
Mortality in PACU, n (%)
|
0 (0)
|
|
Mortality in hospital, n (%)
|
3 (4.8)
|
